immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Immunotherapy against neuronal and brain tumors External link
Filling date: 8 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME External link
Filling date: 8 Sep 2025 Issue date: 2 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Method of treating with a peptide External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jun 2020
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 23 Jun 2020
Application
Utility: TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 8 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 18 Jun 2020
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Method for preparing electrocompetent yeast cells, and method for using said cells External link
Filling date: 8 Sep 2025 Issue date: 16 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 11 Jun 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 4 Jun 2020
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Uterine cancer treatments External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 28 May 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 28 May 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 26 May 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 19 May 2020

Showing 550 to 600 of 820 patents.